6.47
+0.14
+(2.21%)
At close: January 10 at 5:35:05 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-97,130.00
-97,130.00
-53,936.00
-45,048.00
-29,823.00
Investing Cash Flow
-8,095.00
-8,095.00
-12,026.00
-6,232.00
-575.00
Financing Cash Flow
335,290.00
335,290.00
32,211.00
82,679.00
49,929.00
End Cash Position
251,942.00
251,942.00
26,950.00
60,701.00
29,302.00
Capital Expenditure
-265.00
-265.00
-323.00
-47.00
-898.00
Issuance of Capital Stock
353,387.00
353,387.00
46,374.00
69,683.00
26,395.00
Issuance of Debt
55,841.00
55,841.00
--
24,913.00
26,948.00
Repayment of Debt
-40,602.00
-40,602.00
-9,711.00
-5,786.00
-3,414.00
Free Cash Flow
-97,395.00
-97,395.00
-54,259.00
-45,095.00
-30,721.00
12/31/2020 - 6/26/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TNG.PA Transgene SA
0.7590
+2.43%
GNFT.PA Genfit S.A.
3.4300
-1.86%
ABNX.PA ABIONYX Pharma SA
1.2800
-0.16%
ALCLS.PA Cellectis S.A.
1.7820
+0.56%
MEDCL.PA MedinCell S.A.
16.48
-2.25%
0QF.F Moderna, Inc.
41.08
-4.00%
RVU.WA Ryvu Therapeutics S.A.
37.25
-0.67%
HQ1.MU Oruka Therapeutics Inc. R
18.60
0.00%
5KW.F SkinBioTherapeutics plc
0.1720
+1.18%
7IZ.MU Ziccum AB
0.0298
-29.72%